Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

22,471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22,471 results

Not applicableStudy completedNCT00115921
What this trial is testing

Evaluation of Home-Based Management of Fever in Urban Ugandan Children

Who this might be right for
MalariaAnemia
London School of Hygiene and Tropical Medicine 540
Testing effectiveness (Phase 2)Looking for participantsNCT06807606
What this trial is testing

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT03251547
What this trial is testing

Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia

Who this might be right for
Massive HemorrhageMassive Blood LossMassive Blood Transfusion; Thrombocytopenia
Universiti Sains Malaysia 76
Post-approval studies (Phase 4)Study completedNCT03372447
What this trial is testing

Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia

Who this might be right for
Megaloblastic Anemia NosPernicious Anemia
Hospital Universitario Dr. Jose E. Gonzalez 13
Testing effectiveness (Phase 2)Study completedNCT00990249
What this trial is testing

Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaAllogeneic Haematopoietic Stem Cell Transplantation+1 more
M.D. Anderson Cancer Center 120
Very early researchStudy completedNCT05643248
What this trial is testing

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Who this might be right for
Multiple Myeloma
Nanexa AB 9
Not applicableWithdrawnNCT07195617
What this trial is testing

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Ended earlyNCT01748240
What this trial is testing

Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure

Who this might be right for
Myelodysplastic Syndrome
Groupe Francophone des Myelodysplasies 21
Not applicableStudy completedNCT01618734
What this trial is testing

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

Who this might be right for
Immune ThrombocytopeniaThrombopoietin Receptor Agonist
Henri Mondor University Hospital 50
Not applicableLooking for participantsNCT06626893
What this trial is testing

Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention

Who this might be right for
Myeloid Leukemia, AcuteLeukemia, Acute Lymphoblastic
Azienda Ospedaliero-Universitaria di Parma 100
Not applicableStudy completedNCT07113314
What this trial is testing

Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy

Who this might be right for
Febrile Neutropenia (FN)SepsisChemotherapy Treatment
Fondazione IRCCS Policlinico San Matteo di Pavia 160
Not applicableUnknownNCT05383014
What this trial is testing

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Assiut University 82
Not applicableStudy completedNCT01138306
What this trial is testing

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 149
Not applicableStudy completedNCT02308904
What this trial is testing

Reproductive Capacity and Iron Burden in Thalassemia

Who this might be right for
THALASSEMIA MAJOR
UCSF Benioff Children's Hospital Oakland 59
Not applicableUnknownNCT00400504
What this trial is testing

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Who this might be right for
Cancer
Rigshospitalet, Denmark 500
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Not applicableActive Not RecruitingNCT06328647
What this trial is testing

Quantra Point-of-Care Hemostasis Monitoring

Who this might be right for
BleedingHemostatic Disorder
The Cleveland Clinic 666
Not applicableActive Not RecruitingNCT06875947
What this trial is testing

EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

Who this might be right for
Iron Deficiency Anemia of PregnancyPregnancy ComplicationsInflammation+3 more
Universitas Padjadjaran 59
Not applicableStudy completedNCT00572338
What this trial is testing

Therapeutic Research in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 6,388
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Next Page